On June 29, 2014, Governor Andrew M. Cuomo detailed a three-point plan to move us closer to the end of the AIDS epidemic in New York State. The goal is to reduce the number of new HIV infections to just 750 (from an estimated 3,000 in 2013) by the end of 2020 and achieve the first ever decrease in HIV prevalence in New York State.
The three-point plan:

  • Identifies persons with HIV who remain undiagnosed and link them to health care.
  • Links and retains persons diagnosed with HIV in health care to maximize virus suppression so they remain healthy and prevent further transmission.
  • Facilitates access to Pre-Exposure Prophylaxis (PrEP) for persons who engage in high-risk behaviors to keep
    them HIV negative.
Ending the Epidemic (ETE) in New York State will maximize the availability of life-saving, transmission-interrupting treatment for HIV, saving lives and improving the health of New Yorkers. It will move New York from a history of having the worst HIV epidemic in the country to a future where new infections are rare and those living with the disease have normal lifespans with few complications.

Ending the AIDS Epidemic Website

Blueprint Created by New York State’s Ending the Epidemic Task Force

On October 14, 2014, Governor Andrew M. Cuomo announced members of the Ending the Epidemic Task Force (Task Force). The Task Force was established to support Governor Cuomo’s three-point plan. The Task Force developed and synthesized recommendations, presented in New York’s Blueprint to end the epidemic.
Blueprint to End the AIDS Epidemic Executive Summary
Blueprint to End the AIDS Epidemic

Task Force Charge and Mission

The Ending the Epidemic Task Force was established in support of Governor Cuomo’s three-point plan to decrease new HIV infection to 750 per year by the end of 2020. The Task Force provided expert advice to the AIDS Institute on implementation and monitoring strategies, focusing on New York State’s highly successful existing HIV prevention and care efforts to identify undiagnosed persons; link and retain infected individuals in care; and utilize biomedical interventions such as pre- and post-exposure prophylaxis to prevent infections among high-risk individuals, while addressing stigma and discrimination to reduce associated health disparities.